Metro (MRU) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
4 Mar, 2026Executive summary
Q1 sales grew 3.3% year-over-year to CAD 5.3 billion, with adjusted EBITDA up 4.7% and adjusted EPS up 5.5%.
Net earnings declined 12.8% to CAD 226.3 million, but adjusted net earnings rose 1.3% to CAD 248.7 million, reflecting normalization after one-time costs.
Fully diluted EPS fell 9.5% to CAD 1.05, while adjusted EPS grew 5.5% to CAD 1.16.
Operations at the Toronto frozen food distribution center have fully resumed after a costly temporary shutdown.
Dividend per share increased 10.1% to CAD 0.4075.
Financial highlights
Adjusted EBITDA reached CAD 504.2 million, up 4.7% year-over-year, representing 9.5% of sales.
Adjusted net earnings were CAD 248.7 million, up 1.3% year-over-year; adjusted EPS was CAD 1.16, up 5.5%.
Gross margin was CAD 1.04 billion or 19.7% of sales, flat year-over-year.
Operating expenses as a percentage of sales increased to 10.5%, impacted by CAD 20.8 million in direct costs from the Toronto freezer shutdown.
Capital expenditures totaled CAD 61.9 million, down from CAD 89.3 million last year.
Outlook and guidance
CapEx for fiscal 2026 expected to reach approximately CAD 550 million, focused on retail network investment.
Plans to open a dozen discount stores and several major renovations in 2026.
Continued emphasis on value for customers through merchandising, private labels, and loyalty programs amid a challenging economic environment.
Latest events from Metro
- Q2 sales up 5.5%, adjusted EPS up 12.1%, and online sales grew 26.2% year-over-year.MRU
Q2 20259 Jul 2026 - Sales up 3.5% to CAD 6.65B, but net earnings fell 14.6% amid automation and cost pressures.MRU
Q3 20249 Jul 2026 - Q4 saw strong sales and margin gains, supply chain completion, and profit growth expected in 2025.MRU
Q4 20248 Jul 2026 - Strong results, board re-elections, and strategic growth plans highlighted; auditor term limit proposal rejected.MRU
AGM 20258 Jul 2026 - Q2 sales rose 4.1% to CAD 5.1B, with strong pharmacy, discount, and online growth.MRU
Q2 202622 Apr 2026 - Sales up 2.9%, adjusted EPS up 7.8%, online sales up 18.6%, and dividend raised 10.4%.MRU
Q1 20254 Mar 2026 - Q3 sales rose 3.3%, adjusted EPS up 12.6%, with strong pharmacy and discount banner growth.MRU
Q3 20254 Mar 2026 - Q4 sales and earnings rose despite supply chain disruptions, with a strong FY 2026 outlook.MRU
Q4 20254 Mar 2026